EOCN (Eocene) E10: $-1,277.62 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

EOCN Eocene Ltd EOCN
29 GF Score
Price $4.09
! 2 Warning Signs
View Full Analysis

What is Eocene E10?

Eocene EOCN +21.05% 29 E10 is $-1,277.62 as of Jun. 2026. GuruFocus rates EOCN with a GF Score™ of 29/100. The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Eocene's adjusted earnings per share data for the three months ended in Jun. 2026 was $-2.860. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $-1,277.62 for the trailing ten years ended in Jun. 2026.

During the past 3 years, the average E10 Growth Rate was 10.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Eocene was 10.00% per year. The lowest was 10.00% per year. And the median was 10.00% per year.

As of today (2026-09-11), Eocene's current stock price is $4.09. Eocene's E10 for the quarter that ended in Jun. 2026 was $-1,277.62. Eocene's Shiller PE Ratio of today is .


Eocene  (NAS:EOCN) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Eocene E10 Related Terms


Eocene E10 Historical Data

* Premium members only.

The historical data trend for Eocene's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Eocene E10 Chart

Eocene Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 -1,897.69 -1,642.27 -1,529.22 -1,385.30

Eocene Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1,479.77 -1,445.10 -1,385.30 -1,339.98 -1,277.62

EOCN vs ELAB, SILO, APVO: E10 Comparison

For the Biotechnology subindustry, Eocene's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Eocene Shiller PE Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Eocene's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Eocene's Shiller PE Ratio falls into.


EOCN
29GF Score
Eocene Ltd EOCN
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Eocene E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Eocene's adjusted earnings per share data for the three months ended in Jun. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=-2.86/333.9520*333.9520
=-2.860

Current CPI (Jun. 2026) = 333.9520.

Eocene Quarterly Data

per share eps CPI Adj_EPS
201609 -489.600 241.428 -677.233
201612 -576.000 241.432 -796.731
201703 -374.400 243.801 -512.843
201706 -316.800 244.955 -431.900
201709 -331.200 246.819 -448.122
201712 -388.800 246.524 -526.685
201803 -244.800 249.554 -327.590
201806 -244.800 251.989 -324.425
201809 -72.000 252.439 -95.249
201812 -259.200 251.233 -344.542
201903 -244.800 254.202 -321.600
201906 -288.000 256.143 -375.486
201909 -302.400 256.759 -393.315
201912 -561.600 256.974 -729.830
202003 -417.600 258.115 -540.295
202006 -374.400 257.797 -485.000
202009 -460.800 260.280 -591.229
202012 -691.200 260.474 -886.183
202103 -547.200 264.877 -689.900
202106 -475.200 271.696 -584.087
202109 -446.400 274.310 -543.459
202112 -432.000 278.802 -517.454
202203 -352.320 287.504 -409.239
202206 -216.000 296.311 -243.439
202209 -306.240 296.808 -344.564
202212 -144.000 296.797 -162.027
202303 -103.680 301.836 -114.712
202306 -91.200 305.109 -99.821
202309 -27.440 307.789 -29.772
202312 -124.640 306.746 -135.695
202403 -16.800 312.332 -17.963
202406 -13.200 314.175 -14.031
202409 -18.480 315.301 -19.573
202412 -15.420 315.605 -16.316
202503 -4.960 319.799 -5.180
202506 -5.060 322.561 -5.239
202509 -2.640 324.800 -2.714
202512 -7.360 324.054 -7.585
202603 -2.320 330.213 -2.346
202606 -2.860 333.952 -2.860

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of $-1,277.62 mean?
Eocene (EOCN) has a E10 of $-1,277.62 as of Jun. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Eocene and its competitors.
Is Eocene's E10 too high?
Eocene's current E10 is $-1,277.62. Overall, Eocene has a GF Score™ of 29/100, reflecting its overall financial health beyond just this single metric.
How does Eocene's E10 compare to ELAB and SILO?
Eocene's E10 of $-1,277.62 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Biotechnology company?
A good E10 depends on the Biotechnology industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Eocene and its competitors. Eocene's current E10 is $-1,277.62. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Eocene stock overvalued right now?
Eocene (EOCN) has a current E10 of $-1,277.62. The current E10 is $-1,277.62. Eocene's overall GF Score™ is 29/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Eocene (EOCN), the current E10 is $-1,277.62 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Eocene Business Description

Address c/o Meitar Law Offices, 16 Abba Hillel Road, Ramat Gan, ISR, 5250608
Galmed Pharmaceuticals Ltd is a biopharmaceutical company. The company focuses on the development of Aramchol for combination therapy for GI oncological indications. The company is actively pursuing opportunities in the biotech and medtech spaces to expand and diversify its product pipeline targeting GI, cardiometabolic indications and other product candidates.
29GF Score

Get the complete analysis for EOCN

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.09
Price